Last reviewed · How we verify
NCT04314141: PHALLO
Surgical Outcomes, Quality of Life and Patient's Satisfactions With Phalloplasty
trial testing Evaluation of surgical outcomes, quality of life and patient's satisfactions with phalloplasty in Phalloplasty in 143 participants. Completed in 14 November 2020.
14 November 2020
Quick facts
| Lead sponsor | Hospices Civils de Lyon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 143 |
| Start date | 15 May 2020 |
| Primary completion | 14 November 2020 |
| Estimated completion | 14 November 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- Evaluation of surgical outcomes, quality of life and patient's satisfactions with phalloplasty
Conditions studied
- Phalloplasty — all drugs for Phalloplasty →
- Surgery — all drugs for Surgery →
Sponsor
Hospices Civils de Lyon — full company profile →
Who can join
Adults 20 to 73, male only, with Phalloplasty or Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The phalloplasty is a reconstruction technique, consisting of the neophallus creation. It is performed in transgender patients in sex reassignment surgery, or in cismale patients to correct a congenital or acquired lack of penis. There are many surgical techniques, but none is optimal. Surgical and functional outcomes, quality of life and patient's satisfactions with phalloplasty are missing in the international literature. Urological center of Lyon is a reference center of this kind of surgery and has the possibility to evaluate that. In this study, 124 transgender and 19 cismale patients with phalloplasty are eligible. This study will allow us to adapt our practice to the patient's return and improve the information given to patients before their surgery. It will also improve our surgical techniques, depending on the results achieved.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Surgical outcomes, motivations, sexuality, and urinary function of metoidioplasty with semi-rigid prosthesis.
Monchablon B, Morel-Journel N, Carnicelli D, Jurek L, et al · · 2025 · cited 1× · PMID 39981275 · DOI 10.1080/26895269.2023.2279273
Verify or expand the search:
- PubMed search for NCT04314141
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospices Civils de Lyon trials
Trials by the same sponsor.
- NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
- NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
- NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
- NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
- NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04314141 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
- Last refreshed: 4 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04314141.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing